Perspective Therapeutics Inc (AMEX: CATX) is 235.07% higher on its value in year-to-date trading and has touched a low of $2.20 and a high of $19.05 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CATX stock was last observed hovering at around $13.35 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $13.47, the stock is -10.61% and -1.66% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.78 million and changing 0.90% at the moment leaves the stock 20.10% off its SMA200. CATX registered 371.64% gain for a year compared to 6-month gain of 12.25%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -9.05% loss in the last 1 month and extending the period to 3 months gives it a 26.48%, and is -14.96% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.28% over the week and 6.41% over the month.
Perspective Therapeutics Inc (CATX) has around 119 employees, a market worth around $908.28M and $8.84M in sales. Profit margin for the company is -270.46%. Distance from 52-week low is 511.99% and -29.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-6.95%).
Perspective Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -0.22 with sales reaching $140k over the same period.The EPS is expected to grow by 48.40% this year, but quarterly earnings will post -86.40% year-over-year. Quarterly sales are estimated to shrink -93.60% in year-over-year returns.
144.0 institutions hold shares in Perspective Therapeutics Inc (CATX), with institutional investors hold 72.73% of the company’s shares. The shares outstanding are 67.43M, and float is at 48.31M with Short Float at 13.30%. Institutions hold 57.87% of the Float.
Perspective Therapeutics Inc (CATX) Insider Activity
Perspective Therapeutics Inc disclosed in a document filed with the SEC on Jun 17 ’24 that Hunt Jonathan Robert (Chief Financial Officer) bought a total of 1,800 shares of the company’s common stock. The trade occurred on Jun 17 ’24 and was made at $9.81 per share for $17667.0. Following the transaction, the insider now directly holds 35971.0 shares of the CATX stock.
Still, SEC filings show that on Jun 14 ’24, Woods Lori A (Director) acquired 4,587 shares at an average price of $10.90 for $49990.0. The insider now directly holds 159,985 shares of Perspective Therapeutics Inc (CATX).
